Science & Technology
Biomedical Excellence For Safer Transfusion Colaborative
LOS ANGELES, CA
Total revenue
$355K
Total expenses
$449K
Net assets
$751K
Grants received
—
EIN
050602179
Tax year
2024
Mission
We are a unique international collaborative of blood providers industry and academic experts that work together to undertake studies publish guidance and recommend procedures aiming to improve the safety quality and effectiveness of transfusion medicine and cellular therapies worldwide. We use our pooled resources to take on projects and challenges that would be unfeasible to address otherwise. We create international impact in transfusion and cellular therapies for the benefit of donors and patients.
Financials
FY 2024
Revenue
Expenses
People
12 listed
Eileen Selogie MLS MTASCPSBB
Executive Director
$150K
60 hrs/wk
Zbigniew Szczepiorkowski MD PhD
Treasurer Interim President
—
20 hrs/wk
Michael F Murphy MD
Consulting Past President
—
5 hrs/wk
David Stroncek MD
Director
—
5 hrs/wk
David McKenna MD
Director
—
5 hrs/wk
Ralph Vassallo MD
Director
—
5 hrs/wk
Rebecca Cardigan PhD
President
—
20 hrs/wk
Denese Marks PhD
Director
—
5 hrs/wk
Jason Acker PhD MBA
Director
—
5 hrs/wk
Meghan Delaney DO MPH
Director
—
5 hrs/wk
Simon Stanworth MA FCRP PhD FRC
Director
—
5 hrs/wk
Marc Germain MD
Director
—
5 hrs/wk
Independent contractors
ENet Answers
Executive Director